Search Results 231-240 of 7952 for TNF
... TNF agents in patients with IBD. MAC-20531112. Medical Professionals; Vaccine efficacy and antibody response among patients with IBD and recipients of ...
Background: Anaplastic thyroid carcinoma (ATC) is a highly aggressive undifferentiated carcinoma with a mortality rate near 100%. This high.
About this study. The purpose of this study is to evaluate the effectiveness and safety of tebentafusp-based regimens tebentafusp monotherapy and in ...
... tumor necrosis factor receptors OX-40 or CD137); Has participated in prior pembrolizumab (MK-3475) studies; Has a known history of Human Immunodeficiency ...
The purpose of this study is to monitor T cell responses from patients with advanced cancer who are being treated with an anti-PD (programmed death)-1 ...
There is a need for new treatments for myelofibrosis (MF) patients based on laboratory insight into disease pathogenesis. We will use primary patient samples to ...
... tumor necrosis factor agents) within 2 weeks prior to initiation of study treatment or anticipated need for systemic immunosuppressive medications during ...
The purpose of the study is to learn more about inflammatory diseases of the central nervous system (CNS) by collecting patient information, blood sample (which ...
The purpose of this study is to assess the relationship between Nectin-4-positive exosomes in blood and urine and the response to Enfortumab vedotin therapy.
ICD-11 World Health Organization.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.